Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a new study published in ACS Nano.
In the Mirkin laboratory, investigators have harnessed this SNA technology in their work to design precision nanomedicines for use in gene regulation and in cancer immunotherapy with limited unwanted side effects through a systematic development process known as rational vaccinology.
“In the development of vaccines, historically, very little attention has been paid to vaccine structure,” said Mirkin, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “All of the emphasis has been on the components. The premise of rational vaccinology is that, while components are critical, structure is equally important. How you present vaccine components within a modular nanoscale architecture can have a dramatic impact on vaccine efficacy, whether it’s treating infectious disease or cancer.”
In the study, investigators first tested the effects of using different chemical anchoring groups to attach the oligonucleotides—short strands of DNA or RNA—to the surface of the liposomes to prepare SNAs. They found that when increasingly hydrophobic dodecane-based anchoring groups were used, the stability of the nanostructure was significantly improved. When introduced to bone marrow-derived dendritic cells from mice, these more stable SNA constructs exhibited improved cellular uptake compared to the other versions of SNAs that were prepared using other types of anchoring groups, with different chemistries.
“We discovered a way to anchor the oligonucleotides to the surface of the particle that changes the overall stability of the SNA construct, which is critical,” said Jasper Dittmar, a Ph.D. student in the Mirkin laboratory and a co-author of the study. “The beauty of the SNA architecture is that it’s recognized by almost all cell types, immune cells included, and rapidly internalized. You get the vaccine to enter the cells that matter at the stoichiometry you’d like, with the desired number of antigens and adjuvant molecules.”
Scientists in the Mirkin lab then loaded the SNA vaccine with OVA1 (a model peptide derived from egg protein often used in vaccine development) and administered that to mice with lymphoma. The OVA1 SNA-treated mice not only had a greater number of polyfunctional T-cells (which are considered potent against chronic infections and tumors), they also showed a 21-fold reduction in tumor volumes compared to saline-treated mice, according to the study.
To assess the inflammatory side effects of the vaccine, investigators then studied the SNA to see if it activated excessive immune responses in mice. Mice given the treatment did not produce a cytokine storm, a sometimes-fatal side effect of immunotherapies.
Because cytokine storms are associated with severe cases of COVID-19, Mirkin and his research team also created an SNA vaccine where the OVA1 peptide was swapped out for a peptide from the virus that causes COVID-19 (CoV peptide) and administered it to human cells and ultimately mice. The investigators found that the vaccine enhanced antigen-specific, anti-COVID immune responses with minimal adverse side effects.
“Taken together, the results of this study lay a foundation for a new way of developing and delivering vaccines and other precision treatments, regardless of the target disease,” said Michael Evangelopoulos, a Ph.D. student in the Mirkin lab and a co-author of the study.
The findings also highlight the importance of vaccine construction, Mirkin said.
“Structure matters,” Mirkin said. “In a field where we’ve spent very little time focused on the structure of vaccines, we have may have been missing the forest for the trees. It’s a combined understanding of the components and the structural presentation that leads to an efficacious medicine or not.”
Moving forward, the Mirkin group will continue to devise different configurations of SNA vaccines to assess which are the most effective, he said.
“We are spending a lot of time using the SNA platform to figure out the structures that are the most efficacious, and then trying to figure out why that is, what works and then also why it works,” Mirkin said. “We think that by doing that, we’ll be able to create a whole new generation of medicines based upon this concept of rational vaccinology.”
More information: Jasper W. Dittmar et al, Tuning DNA Dissociation from Spherical Nucleic Acids for Enhanced Immunostimulation, ACS Nano (2023). DOI: 10.1021/acsnano.3c04333
Journal information: ACS Nano
News
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
